Trials / Completed
CompletedNCT07319559
Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5124 and DW5124-R, and the effect of food on DW5124, in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW5124 | DW5124 on fasted or fed condition |
| DRUG | DW5124-R | DW5124-R on fasted or fed condition |
Timeline
- Start date
- 2025-05-08
- Primary completion
- 2025-05-11
- Completion
- 2025-06-05
- First posted
- 2026-01-06
- Last updated
- 2026-01-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07319559. Inclusion in this directory is not an endorsement.